Long-term outcomes of PDS appear comparable to monthly ranibizumab injections
- Posted on: Feb 2 2022
- Leave a response
End-of-study results for the extension phase of the phase 2 Ladder trial, comparing use of the Port Delivery System (PDS) and monthly intravitreal injections of ranibizumab for neovascular AMD, suggest comparable efficacy outcomes.
Source: AAO
Posted in: Uncategorized